Ghrelin and GLP-1 Battle for Control of Appetite Through Shared Vagal Nerve Neurons

Ghrelin and GLP-1 functionally antagonize each other through co-localized receptors on vagal afferent neurons — whichever peptide arrives first electrically cancels the effect of the second.

Zhang, Weidong et al.·Scientific reports·2020·Moderate Evidenceanimal
RPEP-05234AnimalModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal
Evidence
Moderate Evidence
Sample
N=Not specified (rat and mouse study)
Participants
Rats and mice in acute feeding studies

What This Study Found

GLP-1 and ghrelin receptors co-localize on vagal afferent neurons innervating the stomach. Each peptide abolishes the electrical and feeding effects of the subsequently administered peptide. Ghrelin generates hyperpolarizing current while GLP-1 generates depolarizing current in isolated nodose ganglia neurons.

Key Numbers

30-min pre-administration of either peptide abolished the other's feeding effect; vagal afferent pathway confirmed.

How They Did This

In vivo feeding studies in rats and mice with sequential peptide administration. Fos expression in nodose ganglia. Electrophysiology of vagal afferents. Calcium imaging in isolated nodose ganglia neurons. Patch-clamp experiments measuring ghrelin and GLP-1 currents.

Why This Research Matters

Understanding how hunger and satiety signals interact at the neural level is fundamental to developing better obesity and appetite disorder treatments. This mutual antagonism through shared neurons reveals a key regulatory checkpoint.

The Bigger Picture

GLP-1 drugs like semaglutide are revolutionizing obesity treatment but we're still learning exactly how they work. This study reveals that one key mechanism is direct competition with ghrelin signaling at the vagal nerve level — the body's main gut-brain communication line.

What This Study Doesn't Tell Us

Animal study — human vagal neuron signaling may differ. The timing dependency (first peptide 'wins') observed in acute experiments may not fully apply to chronic drug administration. In vivo confirmation of electrophysiological findings is indirect.

Questions This Raises

  • ?Does chronic GLP-1 agonist therapy maintain its ability to suppress ghrelin signaling over time?
  • ?Could dual ghrelin antagonist/GLP-1 agonist combinations enhance weight loss beyond GLP-1 alone?
  • ?How does this vagal competition mechanism contribute to the appetite-suppressing effects of bariatric surgery?

Trust & Context

Key Stat:
First wins whichever peptide (ghrelin or GLP-1) reaches vagal neurons first blocks the other's feeding signal
Evidence Grade:
Rigorous multi-method animal study combining behavioral, electrophysiological, imaging, and patch-clamp evidence. Mechanistic clarity is strong but human translation needs confirmation.
Study Age:
Published in 2020. This vagal interaction mechanism is relevant to understanding how GLP-1 drugs like semaglutide suppress appetite.
Original Title:
Functional interaction between Ghrelin and GLP-1 regulates feeding through the vagal afferent system.
Published In:
Scientific reports, 10(1), 18415 (2020)
Database ID:
RPEP-05234

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How do ghrelin and GLP-1 compete in the body?

Both hormones act on the same vagus nerve neurons that connect the gut to the brain. Ghrelin creates a 'hungry' electrical signal and GLP-1 creates a 'full' signal — whichever arrives first locks the neuron into that state, blocking the other.

Why is this relevant to weight loss drugs?

GLP-1 drugs like Ozempic and Wegovy reduce appetite partly by winning this competition on vagal neurons, suppressing ghrelin's hunger signals. Understanding this mechanism could help design even more effective treatments.

Read More on RethinkPeptides

Cite This Study

RPEP-05234·https://rethinkpeptides.com/research/RPEP-05234

APA

Zhang, Weidong; Waise, T M Zaved; Toshinai, Koji; Tsuchimochi, Wakaba; Naznin, Farhana; Islam, Md Nurul; Tanida, Ryota; Sakoda, Hideyuki; Nakazato, Masamitsu. (2020). Functional interaction between Ghrelin and GLP-1 regulates feeding through the vagal afferent system.. Scientific reports, 10(1), 18415. https://doi.org/10.1038/s41598-020-75621-5

MLA

Zhang, Weidong, et al. "Functional interaction between Ghrelin and GLP-1 regulates feeding through the vagal afferent system.." Scientific reports, 2020. https://doi.org/10.1038/s41598-020-75621-5

RethinkPeptides

RethinkPeptides Research Database. "Functional interaction between Ghrelin and GLP-1 regulates f..." RPEP-05234. Retrieved from https://rethinkpeptides.com/research/zhang-2020-functional-interaction-between-ghrelin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.